Breztri (budesonide/glycopyrrolate/formoterol fumarate), meanwhile, has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD).Sales of Breztri were $677 million last year, a rise of 73%, although AZ does not yet break out Airsupra revenues individually, as it is still in the rollout phase.
https://pharmaphorum.com/news/smart-sensor-cleared-use-az-asthma-copd-inhalers
Breztri (budesonide/glycopyrrolate/formoterol fumarate),...
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $12.41M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.7¢ | $1.707K | 100.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1064663 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 913495 | 4 |
View Market Depth
| Last trade - 13.40pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.7¢ |
Change
0.001 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 1.7¢ | 1.7¢ | 1.7¢ | 94771 | ||
| Last updated 13.40pm 07/06/2024 ? | |||||
| ADR (ASX) Chart |